Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,385 | -12,707 | -15,835 | 14,474 | -4,314 |
| Depreciation Amortization | 131 | 135 | 130 | 143 | 2,830 |
| Income taxes - deferred | N/A | N/A | 2,479 | 7,109 | -9,600 |
| Accounts receivable | 126 | 231 | 3,172 | -553 | -2,977 |
| Accounts payable and accrued liabilities | 53 | N/A | -382 | 382 | N/A |
| Other Working Capital | -670 | -668 | -1,178 | -21,357 | 23,211 |
| Other Operating Activity | 2,287 | 6,529 | 6,411 | 3,993 | 10,070 |
| Operating Cash Flow | $12,312 | $-6,480 | $-5,203 | $4,191 | $19,220 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 5,039 | -5,039 | N/A |
| PPE Investments | -131 | -41 | -220 | -143 | -31 |
| Other Investing Activity | 0 | 0 | 0 | 1 | 22 |
| Investing Cash Flow | $-131 | $-41 | $4,819 | $-5,181 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,696 |
| Debt Repayment | N/A | N/A | N/A | N/A | -5,032 |
| Common Stock Issued | 1,293 | 392 | 160 | 20 | 14,265 |
| Other Financing Activity | -1,834 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-541 | $392 | $160 | $20 | $11,929 |
| Beginning Cash Position | 24,045 | 30,174 | 30,398 | 31,368 | 228 |
| End Cash Position | 35,685 | 24,045 | 30,174 | 30,398 | 31,368 |
| Net Cash Flow | $11,640 | $-6,129 | $-224 | $-970 | $31,140 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,312 | -6,480 | -5,203 | 4,191 | 19,220 |
| Capital Expenditure | -131 | -41 | -220 | -143 | -31 |
| Free Cash Flow | 12,181 | -6,521 | -5,423 | 4,048 | 19,189 |